Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 94

1.

2017 consensus of the Asia Pacific Heart Rhythm Society on stroke prevention in atrial fibrillation.

Chiang CE, Okumura K, Zhang S, Chao TF, Siu CW, Wei Lim T, Saxena A, Takahashi Y, Siong Teo W.

J Arrhythm. 2017 Aug;33(4):345-367. doi: 10.1016/j.joa.2017.05.004. Epub 2017 Jun 27.

2.

The Uremic Toxin Indoxyl Sulfate Accelerates Thrombotic Response after Vascular Injury in Animal Models.

Karbowska M, Kaminski TW, Marcinczyk N, Misztal T, Rusak T, Smyk L, Pawlak D.

Toxins (Basel). 2017 Jul 19;9(7). pii: E229. doi: 10.3390/toxins9070229.

3.

Development of next generation sequencing panel for UMOD and association with kidney disease.

Bailie C, Kilner J, Maxwell AP, McKnight AJ.

PLoS One. 2017 Jun 13;12(6):e0178321. doi: 10.1371/journal.pone.0178321. eCollection 2017.

4.

Treatment with enalapril and not diltiazem ameliorated progression of chronic kidney disease in rats, and normalized renal AT1 receptor expression as measured with PET imaging.

Ismail B, deKemp RA, Croteau E, Hadizad T, Burns KD, Beanlands RS, DaSilva JN.

PLoS One. 2017 May 19;12(5):e0177451. doi: 10.1371/journal.pone.0177451. eCollection 2017.

5.

The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.

McManus DD, Saczynski JS, Ward JA, Jaggi K, Bourrell P, Darling C, Goldberg RJ.

J Atr Fibrillation. 2012 Jun 15;5(1):442. doi: 10.4022/jafib.442. eCollection 2012 Jun-Jul. Review.

6.

Assessment of the 10-year risk of cardiovascular disease among a group of patients on maintenance hemodialysis: A cross-sectional study from Cameroon.

Ama Moor VJ, Nansseu JRN, Azingni DBT, Kaze FF.

JRSM Cardiovasc Dis. 2017 Apr 18;6:2048004017705273. doi: 10.1177/2048004017705273. eCollection 2017 Jan-Dec.

7.

Renal Functional Outcomes after Surgery, Ablation, and Active Surveillance of Localized Renal Tumors: A Systematic Review and Meta-Analysis.

Patel HD, Pierorazio PM, Johnson MH, Sharma R, Iyoha E, Allaf ME, Bass EB, Sozio SM.

Clin J Am Soc Nephrol. 2017 Jul 7;12(7):1057-1069. doi: 10.2215/CJN.11941116. Epub 2017 May 8.

PMID:
28483780
8.

Sleep duration and quality in relation to chronic kidney disease and glomerular hyperfiltration in healthy men and women.

Kim CW, Chang Y, Sung E, Yun KE, Jung HS, Ko BJ, Kwon MJ, Hyun YY, Lee KB, Kim H, Shin H, Ryu S.

PLoS One. 2017 Apr 19;12(4):e0175298. doi: 10.1371/journal.pone.0175298. eCollection 2017.

9.

K-alcification Protection in Dialysis Patients: The Underestimated Phenomenon of Vitamin K Deficiency.

Ketteler M, Brandenburg VM.

J Am Soc Nephrol. 2017 Jun;28(6):1667-1668. doi: 10.1681/ASN.2017020180. Epub 2017 Apr 3. No abstract available.

PMID:
28373275
10.

Renocardiovascular Biomarkers: from the Perspective of Managing Chronic Kidney Disease and Cardiovascular Disease.

Niizuma S, Iwanaga Y, Yahata T, Miyazaki S.

Front Cardiovasc Med. 2017 Mar 6;4:10. doi: 10.3389/fcvm.2017.00010. eCollection 2017. Review.

11.

Development of a new risk model for predicting cardiovascular events among hemodialysis patients: Population-based hemodialysis patients from the Japan Dialysis Outcome and Practice Patterns Study (J-DOPPS).

Matsubara Y, Kimachi M, Fukuma S, Onishi Y, Fukuhara S.

PLoS One. 2017 Mar 8;12(3):e0173468. doi: 10.1371/journal.pone.0173468. eCollection 2017.

12.

Sudden Cardiac Death Among Hemodialysis Patients.

Makar MS, Pun PH.

Am J Kidney Dis. 2017 May;69(5):684-695. doi: 10.1053/j.ajkd.2016.12.006. Epub 2017 Feb 17. Review.

PMID:
28223004
13.

Dual Antiplatelet Therapy and Clinical Outcomes after Coronary Drug-Eluting Stent Implantation in Patients on Hemodialysis.

Chen YT, Chen HT, Hsu CY, Chao PW, Kuo SC, Ou SM, Shih CJ.

Clin J Am Soc Nephrol. 2017 Feb 7;12(2):262-271. doi: 10.2215/CJN.04430416.

PMID:
28174317
14.

The burden of major adverse cardiac events in patients with coronary artery disease.

Tsai IT, Wang CP, Lu YC, Hung WC, Wu CC, Lu LF, Chung FM, Hsu CC, Lee YJ, Yu TH.

BMC Cardiovasc Disord. 2017 Jan 4;17(1):1. doi: 10.1186/s12872-016-0436-7.

15.

Matrix Metalloproteinase Neutrophil Gelatinase-Associated Lipocalin Complex Predicts Atrial Fibrillation Recurrence after Electrical Cardioversion in Obese Patients.

Mlodawska E, Tomaszuk-Kazberuk A, Lopatowska P, Waszkiewicz E, Bachorzewska-Gajewska H, Malyszko J, Michniewicz E, Dobrzycki S, Musial WJ.

Cardiorenal Med. 2016 Nov;7(1):11-20. Epub 2016 Aug 12.

PMID:
27994598
16.

Cardiovascular disease in patients with chronic kidney disease: a neglected subgroup.

Subbiah AK, Chhabra YK, Mahajan S.

Heart Asia. 2016 Nov 7;8(2):56-61. eCollection 2016.

17.

Impact of Chronic Kidney Insufficiency on Cardiovascular Outcomes in Patients that Undergo Coronary Revascularization: A Historical Review.

Choong Hou K, Sin Yoong Kong K, Kee Yi Shern T, Tan Wei Chieh J.

ASEAN Heart J. 2016 Nov 16;24:8. eCollection 2016 Nov.

18.

Arterial and Cellular Inflammation in Patients with CKD.

Bernelot Moens SJ, Verweij SL, van der Valk FM, van Capelleveen JC, Kroon J, Versloot M, Verberne HJ, Marquering HA, Duivenvoorden R, Vogt L, Stroes ES.

J Am Soc Nephrol. 2017 Apr;28(4):1278-1285. doi: 10.1681/ASN.2016030317. Epub 2016 Oct 31.

PMID:
27799487
19.

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Verdict 2.

Herzog CA.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2095-2096. Epub 2016 Oct 25. No abstract available.

PMID:
27797902
20.

Use of Oral Anticoagulation in the Management of Atrial Fibrillation in Patients with ESRD: Con.

Keskar V, Sood MM.

Clin J Am Soc Nephrol. 2016 Nov 7;11(11):2085-2092. Epub 2016 Oct 25.

PMID:
27797891

Supplemental Content

Support Center